June 14, 2024
Carboxy Therapy Market

Carboxy Therapy Market Poised to Expand at 11% CAGR by 2031

Carboxy therapy, also known as carbogenesis or carbon dioxide therapy is a minimally invasive cosmetic procedure that uses carbon dioxide gas to treat a variety of conditions on skin surfaces and underlying tissues. It works by injecting carbon dioxide directly into the skin, which stimulates the production of collagen and elastin to reduce wrinkles, sagging skin and cellulite. It also promotes blood circulation to aid healing and rejuvenation.

The global carboxy therapy market is estimated to be valued at US$ 107.7 Mn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the Carboxy Therapy Market Demand are BodyHt, UNITRONIC, DermoEquipos, Alvi Prague, Oxxot, Faireal Medical Laser, DTA Medical, Wavemed, NHC Medical and Beauty, Cosmo Pro, Nick Fanavaran Plasma Company, Beijing Jontelaser Technologies Co., Ltd., MBE Medical Division, and Mezopharma.

The growing awareness about minimally invasive aesthetic procedures and surge in medical tourism are fueling the demand for carboxy therapy globally.

The increasing adoption of carboxy therapy in developed regions such as North America and Europe along with its expansion in emerging economies of Asia Pacific is expected to drive the global market during the forecast period.

Market Key Trends

One of the key trends gaining traction in the global carboxy therapy market is its increasing application in pain management. Carboxy therapy is being widely used to treat muscle and joint pains associated with arthritis, fibromyalgia and other conditions. This is attributed to the anti-inflammatory properties of carbon dioxide that provides relief from chronic and acute inflammation. Various clinical studies have demonstrated the effectiveness of carboxy therapy in reducing joint stiffness and pain. This has broadened the scope of its applications considerably over the years.

Porter’s Analysis

Threat of new entrants: Low capital requirements and no major patents poses a moderate threat of new players venturing into this market. However, existing players have strong brand recognition and distribution channels.

Bargaining power of buyers: There is moderate bargaining power of buyers as there are many players providing Carboxy Therapy and buyers can negotiate on prices. However, switchig costs for buyers are high since treatments require multiple sessions.

Bargaining power of suppliers: The suppliers of materials required for Carboxy Therapy like CO2 gas cylinders face low bargaining power as there are few alternatives and materials have low switching costs.

Threat of new substitutes: There is low threat of substitution as Carboxy Therapy has few alternatives for non-invasive body contouring and cellulite treatment. New methods would require significant R&D and clincal validation before being accepted.

Competitive rivalry: The market has many global and regional players competing on pricing and innovation.

Geographical Regions

North America region accounted for the largest share in the global Carboxy Therapy market in terms of value in 2024 and is expected to maintain its dominance during the forecast period. This is attributed to factors such as rising awareness about non-invasive aesthetic procedures and high discretionary spending on cosmetic treatments in the region.

The Asia Pacific region is expected to be the fastest growing market for Carboxy Therapy during 2024-2031. This growth can be attributed to growing medical tourism industry, rising medical aesthetics spending, and increasing product availability in countries like China, India and Japan. In addition, growing awareness about new treatment options and improving healthcare infrastructure also supports the market growth in the region

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it